What role do extracellular matrix changes contribute to the cardiovascular disease burden of diabetes mellitus?

Keyphrases

• Type 1 Diabetes Mellitus (T1DM) 100%
• Diabetes 100%
• Extracellular Matrix 100%
• Diabetes Burden 100%
• Cardiovascular Disease Burden 100%
• Matrix Change 100%
• Matrix Metalloproteinases 66%
• Cardiovascular Disease 33%
• Experimental Animal Models 33%
• Metalloproteinases 33%
• Drug Effects 33%
• Human Subjects 33%
• Normal Physiology 33%
• Serious Disease 33%
• Cardiomyopathy 33%
• Disabling Conditions 33%
• Extracellular Matrix Turnover 33%
• Vasculopathy 33%
• Pathological State 33%
• Clinical Papers 33%
• Drug Intervention 33%

Medicine and Dentistry

• Diabetes Mellitus 100%
• Cardiovascular Disease 100%
• Diabetes 100%
• Extracellular Matrix 100%
• Disease Burden 100%
• Matrix Metalloproteinase 66%
• Metalloprotease Inhibitor 66%
• Vascular Disease 33%
• Metalloproteinase 33%
• Human Subject 33%
• Myocardial Disease 33%
• Diseases 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Cardiovascular Disease 100%
• Diabetes Mellitus 100%
• Matrix Metalloproteinase 100%
• Tissue Inhibitor of Metalloproteinase 100%
• Vascular Disease 50%
• Experimental Animal 50%
• Metalloproteinase 50%
• Myocardial Disease 50%
• Diseases 50%
• Homo sapiens 50%